Skip to main content

Advertisement

Open Peer Review Reports for: Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
12 Feb 2009 Submitted Original manuscript
17 Apr 2009 Reviewed Reviewer Report - Sophie Barillé-Nion
24 Apr 2009 Reviewed Reviewer Report - Jaafar Bennouna
11 May 2009 Reviewed Reviewer Report - Olivier Coqueret
8 Jun 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 2
8 Jun 2009 Submitted Manuscript version 2
11 Jun 2009 Reviewed Reviewer Report - Sophie Barillé-Nion
1 Jul 2009 Reviewed Reviewer Report - Olivier Coqueret
20 Jul 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 3
20 Jul 2009 Submitted Manuscript version 3
30 Jul 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 4
30 Jul 2009 Submitted Manuscript version 4
6 Aug 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 5
6 Aug 2009 Submitted Manuscript version 5
8 Sep 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 6
8 Sep 2009 Submitted Manuscript version 6
17 Sep 2009 Author responded Author comments - Ivette Emery
Resubmission - Version 7
17 Sep 2009 Submitted Manuscript version 7
Publishing
18 Sep 2009 Editorially accepted
18 Sep 2009 Article published 10.1186/1471-2407-9-333

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement